Dedicated Florida Zofran Attorney Fighting for Children Born With Birth Defects
Aggressively challenging companies marketing unsafe drugs to expectant mothers
Recently, there has been a growing number of lawsuits that have been filed by women who were prescribed Zofran, the brand name of Ondansetron, a nausea preventative drug prescribed for the treatment of morning sickness in pregnant women. However, subsequent studies have linked Zofran use by expectant mothers to an increased risk of birth defects for the unborn child—and some lawsuits are now claiming that GlaxoSmithKline, the manufacturer of Zofran, knew this as far back as the 1980’s.
At the Boca Raton law firm of GS Law PA, our experienced Florida defective drug attorney, Geoffrey S. Schosheim, is here to help all South Florida families and families nationwide who believe they were not adequately warned about the risks of using Zofran while pregnant, resulting in serious health complications for their children.
What risk does Zofran pose to unborn babies?
Use of Zofran by expectant mothers has been linked to the following birth defects and related health issues:
- Congenital respiratory defects, such as underdeveloped lungs
- Club foot
- Premature birth
- Stillbirth and fetal death
- Craniofacial birth defects, such as a cleft palate and other abnormalities of the jaw and tongue
- Cardiovascular anomalies and congenital heart defects
It is estimated that up to 1 million pregnant women use Zofran each year. Estimates of the number of children born in the United States with developmental issues related to Zofran continue to rise, as the first lawsuits began to appear near the beginning of 2015, with many more cases currently being prepared for litigation.
How did GlaxoSmithKline wrongfully market Zofran to pregnant women?
During pregnancy, four out of five women experience the chronic nausea and vomiting known as “morning sickness”. While Zofran was developed to curb post-surgical nausea and to assist cancer patients undergoing chemotherapy or radiotherapy, GlaxoSmithKline chose to advertise Zofran to doctors as a treatment for morning sickness in pregnant women despite the lack of any approval from the US Food and Drug Administration to do so. In 2012, this illegal marketing would become part of what has been described as “the largest health care fraud settlement in U.S. history,” for which GlaxoSmithKline paid a $3 billion dollar fine.
Because the nausea and vomiting caused by morning sickness tends to be most acute during the early weeks of pregnancy, many women relied on Zofran when their unborn child was still in the early stages of development, unaware that the FDA never approved this particular use of the drug. In fact, court documents have indicated that GlaxoSmithKlinenot only failed to conductany clinical studies of the drug’s effect on pregnant women, but that back in the 1980’s, before Zofran’s release, a GlaxoSmithKline study of the drug’s effect on animals indicated clinical signs of similar birth defects—yet never released that data to the public.
Fighting for the rights of those injured by Zofran. Call our Florida Zofran attorney today
Geoffrey S. Schosheim is an experienced Florida Zofran attorney, at the law firm of GS Law PA, who is dedicated to spreading awareness of the potential dangers of Zofran to all Florida families, and to helping children affected at birth by this dangerous drug. We are committed to staying aware of all the latest medical findings and pending litigation related to Zofran. If your family has been affected by an adverse birth, possibly caused by Zofran, we urge you to contact us online, or call our Boca Raton office at (561) 706-5503, to learn more about the rights and remedies available to you and your family.
Contact Us Today!
Geoffrey S. Schosheim, Esq.
4800 N. Federal Highway, Suite B-304 Boca Raton, FL 33431